It’s a fitting conclusion to a tumultuous year for home health supply company Invacare Corp. (NYSE: IVC). In an effort to “reduce complexity” in its business and focus on its core products, the Elyria, Ohio-based company has divested its medical supplies business and reached an agreement with the FDA regarding longstanding quality manufacturing issues. The […]
Regulatory and compliance issues have diverted resources at home health products supplier Invacare (NYSE:IVC) away from “critical priorities” in the company’s business and have resulted in delays of new product introductions and slowed progress on a key globalization initiative. Those issues stem from negotiations with the U.S. Food and Drug Administration over a possible shutdown […]
The progress in artificial intelligence (AI) is reshaping patient care, across various dimensions, from facilitating faster discharge to curating treatment plans and suggesting lifestyle changes.
Home health products supplier Invacare (NYSE:IVC) is still enmeshed in negotiations with the U.S. Food and Drug Administration over a possible shutdown of some wheelchair production at an Elyria, Ohio plant. In December, Invacare announced that the FDA had asked it to enter into a legal agreement that would require the company to suspend “certain” […]
Invacare (NYSE:IVC) plans to move production of a line of manual wheelchairs to Mexico from Ohio, as the home health products company is in the midst of negotiating a legal settlement with the FDA over issues with wheelchair production in the Elyria, Ohio, plant. The Cleveland-area company will shift production of its Solara line of […]
Looking at a possible shutdown of a wheelchair manufacturing facility, home health products maker Invacare (NYSE:IVC) has hired a new compliance and regulatory executive. Doug Uelmen has joined the Elyria, Ohio-based Invacare as senior vice president of quality assurance and regulatory affairs. He boasts more than 30 years experience in quality and regulatory roles, with […]
The U.S. Food and Drug Administration has asked home health products maker Invacare (NYSE:IVC) to enter into a legal agreement that would require the company to suspend “certain” wheelchair manufacturing operations. Under the terms of the FDA’s proposal, Invacare would be required to suspend those operations at its Elyria, Ohio factory until the agency determines […]
Join us on February 26 at 3 pm ET, and we’ll dive into the key areas where practices are losing time and money and provide solutions to overcome them.
Home health products manufacturer Invacare (NYSE:IVC) has acquired a negative-pressure wound therapy system to be sold through its rental business for long-term care providers. But the Elyria, Ohio-based company wouldn’t reveal much more than that, such as the deal’s price or the company it acquired the technology from. Invacare revealed the acquisition in its (pdf) […]
Despite having spent nearly $8 million on federal lobbying since 2005, home health products maker Invacare (NYSE:IVC) doesn’t have much to show for its efforts. Invacare has plenty of reasons to lobby Congress, because federal policy has a greater impact on the Elyria, Ohio-based firm than most. Medicare reimbursement rates determine the price that Invacare’s […]
As Invacare (NYSE:IVC) grapples with what it calls “slowness” in its markets, the medical equipment supplier illustrated with a recent acquisition one market in which it sees potential: rentals to long-term care providers like nursing homes and assisted-living facilities. The Elyria, Ohio-based company (pdf) announced last week when releasing its third-quarter earnings that it had […]
Home health equipment maker Invacare (NYSE:IVC) is laying off about 50 workers worldwide, citing a difficult economy and declining reimbursements to its customers. The layoffs are primarily hitting office workers and affect less than 1 percent of the Elyria, Ohio-based company’s 6,200 global workers, spokeswoman Lara Mahoney said. Mahoney partially blamed the layoffs on falling […]
When it comes to managing inbound phone calls, underperformance has devastating cost implications.
J.B. Richey (left) and Malachi Mixon Invacare (NYSE:IVC) founders Malachi Mixon III and J.B. Richey II have made a $5 million donation to Case Western Reserve University that’s aimed at bolstering the university’s innovation initiatives. The gift will go toward the establishment of a Richey-Mixon Building, which would include space for Case’s school of engineering, […]
A. Malachi Mixon III — known to most as Mal — is one of the Cleveland healthcare industry’s entrepreneurial successes. But that’s just one of the reasons why he is MedCity Media’s first recipient of “The Cities” Medical Mayor award, which recognizes his insight, vision and contributions to healthcare. “The Cities” awards honor the best, […]
Home health products maker Invacare (NYSE: IVC) reported that a controversial new Medicare competitive bidding program for durable medical equipment has had “no significant impact” on its business. The Elyria, Ohio-based company said it expects the program to be “neutral” to its 2011 earnings, according to a statement announcing its second-quarter financial performance. The first […]
Home health equipment manufacturer Invacare (NYSE: IVC) has added the president and CEO of Cleveland nonprofit BioEnterprise to its board. Baiju Shah will join Elyria, Ohio-based Invacare’s board of directors, according to a company statement. BioEnterprise was started in 2002 to help Northeast Ohio biomedical companies grow their businesses. Prior to BioEnterprise, Shah worked with […]
Home health products maker Invacare (NYSE: IVC) raised some prices earlier this year and may increase more to offset rising freight and commodity costs. CEO Gerry Blouch said the rising costs didn’t affect the company’s first quarter financial results much, but that could change during the rest of the year. Invacare reported adjusted first-quarter net […]